471 related articles for article (PubMed ID: 27093979)
1. Risk factors and molecular epidemiology of community-onset, multidrug resistance extended-spectrum β-lactamase-producing
Park SY; Kang CI; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Korean J Intern Med; 2017 Jan; 32(1):146-157. PubMed ID: 27093979
[TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
Am J Infect Control; 2007 Nov; 35(9):606-12. PubMed ID: 17980240
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for multidrug resistance in nosocomial bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Park SY; Kang CI; Joo EJ; Ha YE; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Microb Drug Resist; 2012 Oct; 18(5):518-24. PubMed ID: 22742454
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species.
Hyle EP; Lipworth AD; Zaoutis TE; Nachamkin I; Fishman NO; Bilker WB; Mao X; Lautenbach E
Clin Infect Dis; 2005 May; 40(9):1317-24. PubMed ID: 15825035
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
[TBL] [Abstract][Full Text] [Related]
7. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.
Rodríguez-Baño J; Picón E; Gijón P; Hernández JR; Ruíz M; Peña C; Almela M; Almirante B; Grill F; Colomina J; Giménez M; Oliver A; Horcajada JP; Navarro G; Coloma A; Pascual A;
Clin Infect Dis; 2010 Jan; 50(1):40-8. PubMed ID: 19995215
[TBL] [Abstract][Full Text] [Related]
8. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
[TBL] [Abstract][Full Text] [Related]
9. Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum beta-lactamase (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes.
Apisarnthanarak A; Kiratisin P; Mundy LM
Infect Control Hosp Epidemiol; 2008 Nov; 29(11):1026-34. PubMed ID: 18947321
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and molecular features of sequence type (ST) 131 extended-Spectrum-β-lactamase-producing Escherichia coli in community-onset female genital tract infections.
Kim YA; Lee K; Chung JE
BMC Infect Dis; 2018 Jun; 18(1):250. PubMed ID: 29859045
[TBL] [Abstract][Full Text] [Related]
11. Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Mendonça N; Leitão J; Manageiro V; Ferreira E; Caniça M
Antimicrob Agents Chemother; 2007 Jun; 51(6):1946-55. PubMed ID: 17371815
[TBL] [Abstract][Full Text] [Related]
12. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
Gudiol C; Calatayud L; Garcia-Vidal C; Lora-Tamayo J; Cisnal M; Duarte R; Arnan M; Marin M; Carratalà J; Gudiol F
J Antimicrob Chemother; 2010 Feb; 65(2):333-41. PubMed ID: 19959544
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China.
Tian SF; Chen BY; Chu YZ; Wang S
Can J Microbiol; 2008 Sep; 54(9):781-5. PubMed ID: 18772941
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains.
Kang CI; Wi YM; Lee MY; Ko KS; Chung DR; Peck KR; Lee NY; Song JH
J Clin Microbiol; 2012 Feb; 50(2):312-7. PubMed ID: 22162561
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli from pediatric wards of a Malaysian hospital.
Ho WS; Balan G; Puthucheary S; Kong BH; Lim KT; Tan LK; Koh XP; Yeo CC; Thong KL
Microb Drug Resist; 2012 Aug; 18(4):408-16. PubMed ID: 22394084
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.
Ha YE; Kang CI; Cha MK; Park SY; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Int J Antimicrob Agents; 2013 Nov; 42(5):403-9. PubMed ID: 24071027
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of extended-spectrum β-lactamase-producing multidrug-resistant Escherichia coli among isolates from community-acquired infections and in silico structural modeling of an ESBL protein.
Rajapandiyan K; Shanthi S; Vijayalakshmi P; Daisy P; Murugan M; Ranjitsingh AJ
Microb Drug Resist; 2014 Apr; 20(2):170-6. PubMed ID: 24228708
[TBL] [Abstract][Full Text] [Related]
18. The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel.
Karfunkel D; Carmeli Y; Chmelnitsky I; Kotlovsky T; Navon-Venezia S
Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):513-21. PubMed ID: 23117265
[TBL] [Abstract][Full Text] [Related]
19. Emergence of extended spectrum-β-lactamase-producing Escherichia coli O25b-ST131: a major community-acquired uropathogen in infants.
Cheng MF; Chen WL; Hung WY; Huang IF; Chiou YH; Chen YS; Lee SS; Hung CH; Wang JL
Pediatr Infect Dis J; 2015 May; 34(5):469-75. PubMed ID: 25879646
[TBL] [Abstract][Full Text] [Related]
20. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
